View in EDS

Targeting the αVβ3/NgR2 pathway in neuroendocrine prostate cancer.

Saved in:
Bibliographic Details
Title: Targeting the αVβ3/NgR2 pathway in neuroendocrine prostate cancer.
Authors: Testa A; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, United States; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, United States., Quaglia F; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, United States; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, United States., Naranjo NM; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, United States; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, United States., Verrillo CE; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, United States; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, United States., Shields CD; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, United States; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, United States., Lin S; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, United States; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, United States., Pickles MW; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, United States; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, United States., Hamza DF; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, United States; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, United States., Von Schalscha T; Department of Pathology, Moores Cancer Center, and Sanford Consortium for Regenerative Medicine, University of California San Diego, La Jolla, CA, United States., Cheresh DA; Department of Pathology, Moores Cancer Center, and Sanford Consortium for Regenerative Medicine, University of California San Diego, La Jolla, CA, United States., Leiby B; Division of Biostatistics, Department of Pharmacology, Physiology, and Cancer Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, United States., Liu Q; Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, PA, United States., Ding J; Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, PA, United States., Kelly WK; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA, United States., Hooper DC; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, United States; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, United States., Corey E; Department of Urology, University of Washington, Seattle, WA, United States., Plow EF; Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, United States., Altieri DC; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA, United States., Languino LR; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, United States; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, United States.
Source: Matrix biology : journal of the International Society for Matrix Biology [Matrix Biol] 2023 Dec; Vol. 124, pp. 49-62. Date of Electronic Publication: 2023 Nov 11.
Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9432592 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-1802 (Electronic) Linking ISSN: 0945053X NLM ISO Abbreviation: Matrix Biol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37956856
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Targeting the αVβ3/NgR2 pathway in neuroendocrine prostate cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Testa+A%22">Testa A</searchLink>; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, United States; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, United States.<br /><searchLink fieldCode="AU" term="%22Quaglia+F%22">Quaglia F</searchLink>; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, United States; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, United States.<br /><searchLink fieldCode="AU" term="%22Naranjo+NM%22">Naranjo NM</searchLink>; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, United States; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, United States.<br /><searchLink fieldCode="AU" term="%22Verrillo+CE%22">Verrillo CE</searchLink>; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, United States; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, United States.<br /><searchLink fieldCode="AU" term="%22Shields+CD%22">Shields CD</searchLink>; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, United States; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, United States.<br /><searchLink fieldCode="AU" term="%22Lin+S%22">Lin S</searchLink>; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, United States; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, United States.<br /><searchLink fieldCode="AU" term="%22Pickles+MW%22">Pickles MW</searchLink>; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, United States; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, United States.<br /><searchLink fieldCode="AU" term="%22Hamza+DF%22">Hamza DF</searchLink>; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, United States; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, United States.<br /><searchLink fieldCode="AU" term="%22Von+Schalscha+T%22">Von Schalscha T</searchLink>; Department of Pathology, Moores Cancer Center, and Sanford Consortium for Regenerative Medicine, University of California San Diego, La Jolla, CA, United States.<br /><searchLink fieldCode="AU" term="%22Cheresh+DA%22">Cheresh DA</searchLink>; Department of Pathology, Moores Cancer Center, and Sanford Consortium for Regenerative Medicine, University of California San Diego, La Jolla, CA, United States.<br /><searchLink fieldCode="AU" term="%22Leiby+B%22">Leiby B</searchLink>; Division of Biostatistics, Department of Pharmacology, Physiology, and Cancer Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, United States.<br /><searchLink fieldCode="AU" term="%22Liu+Q%22">Liu Q</searchLink>; Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, PA, United States.<br /><searchLink fieldCode="AU" term="%22Ding+J%22">Ding J</searchLink>; Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, PA, United States.<br /><searchLink fieldCode="AU" term="%22Kelly+WK%22">Kelly WK</searchLink>; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA, United States.<br /><searchLink fieldCode="AU" term="%22Hooper+DC%22">Hooper DC</searchLink>; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, United States; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, United States.<br /><searchLink fieldCode="AU" term="%22Corey+E%22">Corey E</searchLink>; Department of Urology, University of Washington, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Plow+EF%22">Plow EF</searchLink>; Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, United States.<br /><searchLink fieldCode="AU" term="%22Altieri+DC%22">Altieri DC</searchLink>; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA, United States.<br /><searchLink fieldCode="AU" term="%22Languino+LR%22">Languino LR</searchLink>; Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, United States; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229432592%22">Matrix biology : journal of the International Society for Matrix Biology</searchLink> [Matrix Biol] 2023 Dec; Vol. 124, pp. 49-62. <i>Date of Electronic Publication: </i>2023 Nov 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>9432592 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1569-1802 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220945053X%22">0945053X </searchLink><i>NLM ISO Abbreviation: </i>Matrix Biol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37956856
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.matbio.2023.11.003
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 49
    Titles:
      – TitleFull: Targeting the αVβ3/NgR2 pathway in neuroendocrine prostate cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Testa A
      – PersonEntity:
          Name:
            NameFull: Quaglia F
      – PersonEntity:
          Name:
            NameFull: Naranjo NM
      – PersonEntity:
          Name:
            NameFull: Verrillo CE
      – PersonEntity:
          Name:
            NameFull: Shields CD
      – PersonEntity:
          Name:
            NameFull: Lin S
      – PersonEntity:
          Name:
            NameFull: Pickles MW
      – PersonEntity:
          Name:
            NameFull: Hamza DF
      – PersonEntity:
          Name:
            NameFull: Von Schalscha T
      – PersonEntity:
          Name:
            NameFull: Cheresh DA
      – PersonEntity:
          Name:
            NameFull: Leiby B
      – PersonEntity:
          Name:
            NameFull: Liu Q
      – PersonEntity:
          Name:
            NameFull: Ding J
      – PersonEntity:
          Name:
            NameFull: Kelly WK
      – PersonEntity:
          Name:
            NameFull: Hooper DC
      – PersonEntity:
          Name:
            NameFull: Corey E
      – PersonEntity:
          Name:
            NameFull: Plow EF
      – PersonEntity:
          Name:
            NameFull: Altieri DC
      – PersonEntity:
          Name:
            NameFull: Languino LR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2023 Dec
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1569-1802
          Numbering:
            – Type: volume
              Value: 124
          Titles:
            – TitleFull: Matrix biology : journal of the International Society for Matrix Biology
              Type: main
ResultId 1